SSRIs are effective for treatment of hypersensitive esophagus

A study in November's issue of the American Journal of Gastroenterology investigates the use selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus.

Ambulatory 24-hour pH–impedance monitoring can be used to assess the relationship of persistent symptoms and reflux episodes, despite proton pump inhibitor (PPI) therapy.

Using this technique, Dr Nikos Viazis and colleagues from Greece identified patients with hypersensitive esophagus, and evaluated the effect of selective serotonin reuptake inhibitors (SSRIs) on their symptoms.